Shimon Sakaguchi

 

 


 

Dr. Sakaguchi, M.D., Ph.D. Professor, Osaka University, discovered regulatory T (Treg) cells, which compose of five percent of T cells and are specialized for immuno-supression. He has being studying the molecular basis of the development of naturally occurring Treg cells, and also human Treg cells, in particular, analyzing anti-tumor immune responses against adult T-cell leukemia, shedding new light on cancer immunotherapy. He was elected as a member of National Academy of Sciences in 2012 and was also selected as one of the “Highly Cited Researchers” by Thomson Reuters CO, USA.




Customize your search:

E.g., 2016-12-10
E.g., 2016-12-10
E.g., 2016-12-10
Jul 7th 2015

Basic principles of immunology including the latest topics leading to novel therapeutic approaches.

No votes yet